Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2016 1
2017 1
2019 5
2020 6
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.
Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, Shastri A, Sica RA, Gritsman K, Mehta V, Kabarriti R, Goel S, Verma A, Braunschweig I, Kornblum N, Mantzaris I. Gonzalez-Lugo JD, et al. Among authors: sica ra. Br J Haematol. 2020 Aug;190(3):e130-e133. doi: 10.1111/bjh.16906. Epub 2020 Jun 24. Br J Haematol. 2020. PMID: 32479664 Free PMC article.
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data.
Kaur G, Mejia Saldarriaga M, Shah N, Catamero DD, Yue L, Ashai N, Goradia N, Heisler J, Xiao Z, Ghalib N, Aaron T, Cole D, Foreman R, Mantzaris I, Derman O, Bachier L, Sica RA, Kornblum N, Braunschweig I, Shastri A, Goel S, Verma A, Janakiram M. Kaur G, et al. Among authors: sica ra. Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e384-e397. doi: 10.1016/j.clml.2020.11.013. Epub 2020 Nov 21. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33339770
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis.
Abbasi A, Peeke S, Shah N, Mustafa J, Khatun F, Lombardo A, Abreu M, Elkind R, Fehn K, de Castro A, Wang Y, Derman O, Nelson R, Uehlinger J, Gritsman K, Sica RA, Kornblum N, Mantzaris I, Shastri A, Janakiram M, Goldfinger M, Verma A, Braunschweig I, Bachier-Rodriguez L. Abbasi A, et al. Among authors: sica ra. J Hematol Oncol. 2020 Jan 3;13(1):1. doi: 10.1186/s13045-019-0838-y. J Hematol Oncol. 2020. PMID: 31900191 Free PMC article.
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
Shah UA, Shah N, Qiao B, Acuna-Villaorduna A, Pradhan K, Adrianzen Herrera D, Sica RA, Shastri A, Mantzaris I, Derman O, Kornblum N, Braunschweig I, Ye BH, Verma A, Janakiram M. Shah UA, et al. Among authors: sica ra. Cancer. 2020 Feb 1;126(3):567-574. doi: 10.1002/cncr.32556. Epub 2019 Nov 26. Cancer. 2020. PMID: 31769871 Free PMC article.
Seroconversion rates following COVID-19 vaccination among patients with cancer.
Thakkar A, Gonzalez-Lugo JD, Goradia N, Gali R, Shapiro LC, Pradhan K, Rahman S, Kim SY, Ko B, Sica RA, Kornblum N, Bachier-Rodriguez L, McCort M, Goel S, Perez-Soler R, Packer S, Sparano J, Gartrell B, Makower D, Goldstein YD, Wolgast L, Verma A, Halmos B. Thakkar A, et al. Among authors: sica ra. Cancer Cell. 2021 Jun 5:S1535-6108(21)00285-3. doi: 10.1016/j.ccell.2021.06.002. Online ahead of print. Cancer Cell. 2021. PMID: 34133951 Free PMC article.
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
Wei Y, Ren X, Galbo PM Jr, Moerdler S, Wang H, Sica RA, Etemad-Gilbertson B, Shi L, Zhu L, Tang X, Lin Q, Peng M, Guan F, Zheng D, Chinai JM, Zang X. Wei Y, et al. Among authors: sica ra. Sci Immunol. 2021 Jul 9;6(61):eabf9792. doi: 10.1126/sciimmunol.abf9792. Sci Immunol. 2021. PMID: 34244312
High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for staging.
Acuna-Villaorduna A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, Sica RA, Shah U, Shah N, Kornblum N, Braunschweig I, Derman O, Mantzaris I, Shastri A, Wang Y, Verma A, Zalta B, Janakiram M. Acuna-Villaorduna A, et al. Among authors: sica ra. Leuk Lymphoma. 2019 Dec;60(13):3272-3276. doi: 10.1080/10428194.2019.1627543. Epub 2019 Jun 17. Leuk Lymphoma. 2019. PMID: 31204876 Free PMC article.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page